Synonym: EB0502 LbCas12a
Species: Lachnospiraceae bacterium
Protein Accession: QKH13994
Purity: 95%
Endotoxin Level:
<1 EU/μg
Biological Activity: N/A
Expression System: Escherichia coli
Fusion Tag: N/A
Predicted Molecular Mass: 162 kDa
Formulation: Supplied as a lyophilized powder
Reconstitution: Reconstitute in PBS, pH 7.4 to a concentration of 0.1-1.0
mg/ml
Storage & Stability: Store lyophilized protein at -20°C. Reconstituted
protein can be stored at 4°C for a few days or at -20°C for longer periods.
Avoid repeated freeze/thaw cycles.
FAQ
What is EB0502 LbCas12a and how does it work in the feed industry?
EB0502
LbCas12a is a CRISPR-associated enzyme derived from the bacterium
Lachnospiraceae bacterium ND2006. It is a robust genome-editing tool that has
been adapted for various applications in the feed industry. The enzyme works by
targeting specific DNA sequences and inducing double-stranded breaks at precise
locations within the genome. This targeted cleavage facilitates the introduction
of genetic modifications, allowing for the enhancement of desirable traits in
livestock or the development of novel feed ingredients. In the feed industry,
EB0502 LbCas12a can be employed to increase the nutritional value of feed,
improve the health and productivity of livestock, and reduce reliance on
antibiotics and other chemical additives. Its high specificity and efficiency
make it a valuable tool for advancing agricultural biotechnology and ensuring a
more sustainable and efficient food production system.
What are the
benefits of using EB0502 LbCas12a in animal feed production?
The use of
EB0502 LbCas12a in animal feed production offers several significant benefits.
By enabling precise genetic modifications, it allows for the development of feed
that is more nutritionally balanced, which can enhance the growth rates and
overall health of livestock. Additionally, it can be used to create feed
ingredients that are more easily digestible, thereby improving feed conversion
ratios and reducing waste. This technology also offers the potential to develop
livestock with enhanced disease resistance, which can lead to reduced dependency
on antibiotics and other veterinary drugs. Furthermore, EB0502 LbCas12a supports
the creation of environmentally sustainable feed solutions by facilitating the
development of crops that require fewer resources to grow, contributing to lower
greenhouse gas emissions and less environmental degradation. These benefits
collectively promote a more sustainable, efficient, and productive agricultural
system.
How does EB0502 LbCas12a compare to other genome-editing
technologies currently used in the feed industry?
EB0502 LbCas12a stands
out among genome-editing technologies due to its unique characteristics and
advantages. Unlike other commonly used tools such as CRISPR/Cas9, LbCas12a
recognizes and binds to different protospacer adjacent motif (PAM) sequences,
which broadens the range of potential target sites within a genome. This
versatility enhances its precision in making genetic modifications.
Additionally, EB0502 LbCas12a cuts DNA in a staggered fashion, producing sticky
ends rather than blunt ends, which facilitates more efficient and accurate
insertion of desired genetic material. The enzyme's high specificity reduces the
risk of off-target effects, making it safer for use in modifying genes
associated with complex traits in animals or feed crops. It also offers
advantages in multiplexing, allowing for the simultaneous editing of multiple
genes within a single organism. These features make EB0502 LbCas12a a highly
effective and versatile tool for advancing genetic improvement programs in the
feed industry.
What ethical considerations are associated with the use of
EB0502 LbCas12a in the feed industry?
The use of EB0502 LbCas12a in the
feed industry raises several ethical considerations that need to be addressed.
One major concern is the welfare of the genetically modified animals, such as
ensuring that the modifications do not cause unintended harm or suffering. There
is also the broader issue of environmental impact, where rigorous risk
assessments must be conducted to evaluate the potential effects of releasing
genetically modified organisms into the ecosystem. The ethical implications of
gene editing on biodiversity and ecosystem balance must be carefully considered.
Additionally, there are societal and cultural concerns related to the acceptance
of genetically modified organisms (GMOs) in food production. Public perception
and consumer trust are critical, so transparency about the use of such
technologies and their benefits and risks is essential. Finally, there is the
need for regulatory frameworks that ensure the responsible and ethical use of
genome-editing technologies, ensuring that they are employed safely and
equitably in the pursuit of agricultural and environmental
sustainability.
Can EB0502 LbCas12a be used to enhance the nutritional
content of feed ingredients?
Yes, EB0502 LbCas12a can be utilised to
enhance the nutritional content of feed ingredients significantly. By enabling
precise modifications to the genetic makeup of feed crops, this technology can
result in the development of plants that have increased levels of essential
nutrients such as proteins, vitamins, and minerals. For instance, genes
responsible for the synthesis of amino acids or micronutrients can be
upregulated, leading to crops with higher nutritional value. Additionally,
antisense RNA or other gene silencing techniques can be employed to reduce the
levels of anti-nutritional factors in feed ingredients, thereby improving their
digestibility and nutritional quality. These genetic enhancements can lead to
the production of more nutritionally balanced feed, which can support better
growth, health, and productivity in livestock. By addressing specific
nutritional deficiencies in animal diets, EB0502 LbCas12a contributes to the
development of tailored feed solutions that meet the precise nutritional needs
of various livestock species.